ONHS Report: HT942526JWMRPMMRDA

DoW Joint Warfighter Medical, Military Medical Research and Development Award

Solicitation ID: HT942526JWMRPMMRDA

Agency: DHA

Type: Cooperative Agreement

Deadline: 2026-11-16T00:00:00 ET

Eligibility: Yes (Team Member)

Funding: Approximately $8.8M is allotted to fund awards with total cost caps of $1.4M per award for the MMRDA, and $3.0M per award for the MMRDA-CRCTO.

Doc Type: BAA

Clearance: No

Program Manager: help@eBRAP.org

Last Updated: 2026-08-19 14:46

Analyzed File: HT942526JWMRPMMRDA_GG2.pdf

Eligibility Reasoning

Federally Funded Research and Development Centers (FFRDCs) are not eligible to directly receive awards under this Broad Agency Announcement (BAA). However, teaming arrangements between FFRDCs and eligible organizations are allowed as long as they are permitted under the sponsoring agreement between the federal government and the specific FFRDC.

Note: This is an AI-generated summary...

Summary

The Fiscal Year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) funds the logical continuation of previously awarded Department of War (DOW) research to accelerate medical solutions for military personnel. A key eligibility criterion is that applicants must have previously received DOW core or Congressional Special Interest funding. The program supports late-stage preclinical studies, technology development, and clinical research, with projects required to be at a Technology/Knowledge Readiness Level (TRL/KRL) of 5 or higher. A specific option, the MMRDA-Clinical Research or Clinical Trial Option (MMRDA-CRCTO), is available for projects involving human subjects. Proposals must address one of the following focus areas: non-vaccine approaches for diarrheal disease and antivirals; hemorrhage mitigation and trauma resuscitation; treatment for temperature-related injuries; forward treatment of musculoskeletal injuries; or medical countermeasures to radiation exposure. The program expects to fund approximately two MMRDA awards up to $1.4M each and two MMRDA-CRCTO awards up to $3.0M each, for a maximum performance period of 3 years.

Overall Technical Areas

Diarrheal Disease PreventionBroad-Spectrum Antiviral DevelopmentHemorrhage Mitigation SolutionsTrauma Resuscitation TherapeuticsBlood and Biologic ProductsTemperature Extreme Injury TreatmentMusculoskeletal Injury TreatmentRadiation Medical CountermeasuresBiodosimetry Screening ToolsPost-exposure Radiation TherapeuticsPreclinical Animal StudiesClinical Trial DesignMedical Device DevelopmentPharmaceutical Candidate DevelopmentTranslational Research

Probable LBNL Areas

N/A

Focus Areas

Example Priorities:

Non-vaccine approaches to prevent endemic diarrheal disease and broad-spectrum antivirals to prevent and/or treat emerging or endemic infectious diseases, excluding malaria

Specific Technical Skills:

VirologyMicrobiologyPharmacologyDrug DevelopmentMedicinal ChemistryEpidemiologyImmunologyInfectious Disease ModelingClinical Trial Design

Potential PIs for this Area:

Name	Score	Organization

Example Priorities:

Solutions to mitigate hemorrhage and/or support trauma resuscitation, including but not limited to blood, biologics and therapeutics

Specific Technical Skills:

Trauma MedicineCritical Care MedicineHematologyTransfusion MedicineBiologics DevelopmentPharmaceutical FormulationHemostatic AgentsMedical Device EngineeringFluid Resuscitation

Potential PIs for this Area:

Name	Score	Organization

Example Priorities:

Solutions to prevent and/or treat injuries due to temperature extremes (e.g., heat exhaustion, heat stroke, hypothermia and frostbite)

Specific Technical Skills:

Environmental PhysiologyEmergency MedicineThermal BiologyPathophysiologyTherapeutic DevelopmentWearable SensorsPhysiological MonitoringClinical Protocol DevelopmentDermatology

Potential PIs for this Area:

Name	Score	Organization

Example Priorities:

Solutions to support forward treatment of musculoskeletal injuries (MSKI) and reduce impact of MSKI on operational effectiveness

Specific Technical Skills:

OrthopedicsSports MedicineBiomechanicsRehabilitation ScienceRegenerative MedicinePortable ImagingField MedicinePain ManagementSurgical Techniques

Potential PIs for this Area:

Name	Score	Organization

Example Priorities:

Medical countermeasures to radiation exposure, including pre-exposure prophylaxis, biodosimetry (inclusive of rapid screening and diagnostic tools), and post-exposure treatments (excluding cytokines)

Specific Technical Skills:

RadiobiologyToxicologyPharmacologyDrug DiscoveryBiodosimetryDiagnostic DevelopmentRadiation PhysicsCellular TherapyMedical ImagingHematopoietic Stem Cell Biology

Potential PIs for this Area:

Name	Score	Organization

Potential LBNL PIs (Overall)

Note on PI Matching: These suggestions are generated through an AI-driven semantic analysis of LBNL staff profiles.

Name	Score	Organization
Amy Kronenberg	0.76	BSA \| Biological Systems & Engineering \| Biodesign Dept · Radiation Medical Countermeasures
Natalia Molchanova	0.74	ESA \| MF \| MF Biological Facility · Broad-Spectrum Antiviral Development
Jamie Inman	0.74	BSA \| Biological Systems & Engineering \| Department of BioEngineering and BioMedical Sciences · Biodosimetry Screening Tools
Peter Tennessen	0.73	PSA \| Engineering \| Mechanical Engineering · Medical Device Development
Jian-Hua Mao	0.72	BSA \| Biological Systems & Engineering \| Department of BioEngineering and BioMedical Sciences · Preclinical Animal Studies
Eleanor Zizka	0.72	BSA \| Biological Systems & Engineering \| Department of BioEngineering and BioMedical Sciences · Clinical Trial Design
Jennifer Rosenbluth	0.72	· Translational Research
Gerard Marriott	0.71	BSA \| Molecular Biophysics & Integrated Bioimaging \| Cellular & Tissue Image · Pharmaceutical Candidate Development
Yi-Chuan Lu	0.71	EESA \| CESD \| Earth System Sciences · Temperature Extreme Injury Treatment
Reginald Lee	0.71	PSA \| Engineering \| Mechanical Engineering · Hemorrhage Mitigation Solutions

Fundamental Research Exemption (FRE)

In accordance with National Security Presidential Memorandum-33 and all associated laws, all fundamental research funded by the DOW must be evaluated for affiliations with foreign entities.